MedPage Today  Oct 10  Comment 
(MedPage Today) -- Consistent benefit with atezolizumab, irrespective of ligand expression
Motley Fool  Sep 30  Comment 
Ligand Pharmaceuticals has returned over 1,160% since the beginning of 2011.
Motley Fool  Sep 27  Comment 
Shares drop in response to its partner Amgen reporting less-than-stellar clinical data.
Forbes  Sep 27  Comment 
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Gilead Sciences, Inc. (NASD: GILD), where a total volume of 43,947 contracts has been traded thus far today, a contract volume...
newratings.com  Sep 13  Comment 
WASHINGTON (dpa-AFX) - Ligand Pharmaceuticals Inc. (LGND) announced the initiation of a Phase 2 clinical trial with the company's glucagon receptor antagonist LGD-6972 for the treatment of type 2 diabetes mellitus. The randomized,...
FierceBiotech  Sep 7  Comment 
Retrophin, Ligand up on positive PhII data in rare kidney disorder slawrence Wed, 09/07/2016 - 10:32
newratings.com  Sep 7  Comment 
WASHINGTON (dpa-AFX) - Ligand Pharmaceuticals Inc. (LGND) partner Retrophin, Inc. (RTRX) reported positive top-line results from the Phase 2 DUET study of sparsentan for the treatment of focal segmental glomerulosclerosis, a kidney disorder...
Benzinga  Sep 7  Comment 
  Analysts at CIBC upgraded Spectra Energy Corp. (NYSE: SE) from Sector Performer to Outperformer. Spectra Energy shares declined 1.10 percent to $40.55 in pre-market trading. Deutsche Bank upgraded Ligand Pharmaceuticals Inc. ...

You may also be interested in articles related to Ligand Pharmaceuticals (LGND):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki